HIGHLIGHTS

This 2016 edition was a unique opportunity to find and discuss best practices. Participants found out how best practices might apply to their current or future pricing organisational challenges. The most influential industry experts shared state-of-the-art insights, using real business cases across Pharma-Biotech and MedTech.

To get a glimpse of this 2016 edition, we have edited a Post Forum Report of the 6th EPP Life Sciences Pricing Forum as well as we shared a video on YouTube.  Feel free to have a look at both of them to get convinced of the added value this forum can give to you and your collagues in your search for answers to the multiple pricing challenges your industry will come across with.

Hope to see you back this year for the 7th EPP Life Sciences Pricing Forum!

Best regards,

Els Landuyt | Forum Manager


 Post Forum Report over 2016_COVERRead all about our reflections on the 6th EPP Life Sciences Pricing Forum in this Post Forum Report.

How did our moderator experience the Forum?

'It was a privilege and a pleasure for me to moderate this year’s EPP Life Science forum, and my sincere thanks to EPP and their partners, to our first class presenters and to all our engaged and enthusiastic participants for making this 6th forum such a great success. This year’s theme ‘Pricing under Pressure’ obviously resonated very strongly with all who attended, and stimulated
lots of high quality discussion, debate and ideas sharing among the participants from both pharma and MedTech.

The quality of the plenary presentations, the panel discussions and the breakout sessions this year
was consistently excellent, with industry leaders from across the globe tackling some of the most
fundamental pricing issues facing life sciences today. These ranged from the growing sophistication
and demands of payer systems, through the challenges of pricing innovative technologies and the most effective ways to manage tendering, innovative contracting and using data analytics, right through to optimizing pricing around loss of exclusivity and the usefulness of brain scanning technology in determining perceived value and willingness to pay.

Having been challenged to make the most of this learning opportunity that had been developed by pricing specialists for pricing specialists, it was so rewarding to see how actively everyone got engaged throughout the event, with lots of great probing questions and challengers for the presenters, many thought-provoking omments and points of discussion in the panel discussions and breakout groups, and loads of sharing of information, ideas and experiences during the coffee and lunch breaks and during the very enjoyable evening cruise on lake Geneva.
It was also great to see how the forum provided a golden opportunity for old colleagues and professional acquaintances to catch up, and for all the participants to make new contacts and grow their networks.

We began the forum by everyone making a note of what he or she wanted to take away from the event. As we reviewed these towards the end of the two days, it became clear that the vast majority of the participants’ learning needs and expectations for the event had been met and, in many cases, surpassed.

Some of those key learning points included:
•The growing need for life sciences companies to be able to demonstrate and communicate the relevant value of their products as solutions to meeting payers’ needs, in order to negotiate optimal prices.
•The limitations of the revenue potential of ‘emerging markets’ and the difficulties of optimizing pricing with systems that are sometimes not transparent or consistent
•The appropriateness and potential usefulness of ‘innovative’ pricing strategies as alternatives to traditional approaches, and how best to price different types of innovation in pharma and MedTech
•The importance of well designed price guidelines and indices in effective payer negotiations.
•The usefulness and the limitations of different types of analytics in effective pricing
•The evolving role of the strategic pricing function and how to meet both global and local needs with an effective tendering management system.
•The commercial importance of effectively managing pricing around loss of exclusivity
•The development and potential of neurophysiology and brain scanning techniques in determining optimal prices and willingness to pay.

At the end of the forum, and in subsequent emails and feedback, the majority of participants declared that the forum had met their needs and been a great success, with many adding that they were looking forward to coming again next year. I share their views, and can’t wait to join them!

Check for yourself! And join us next year for the 7th EPP Life Sciences Pricing Forum, scheduled on October 3-4, 2017. Hope to see you then again in Montreux.'

Michael_Herepath

PRESENTATIONS

All the presentations are shared with the Forum participants and EPP Members.  Download all presentations here.
You are not yet an EPP Member?  Read all about the benefits here and join the EPP community now.

Get a glimpse of the 7th EPP Life Sciences Pricing Forum!

 P1180430 Room P1180820 P1180572  P1180411 P1190050
 P1180175  P1180159  P1180066  P1190219  P1180465  P1180617
 P1180411  P1180607  P1180435  P1180225  P1180280
 P1180622

 

EPP PARTNERSHIPS